Evogene Ltd. (EVGN)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Evogene Ltd. (EVGN)
Company Performance

Current Price

as of Oct 15, 2024

$2.51

P/E Ratio

N/A

Market Cap

$13.68M

Description

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, Industrial Applications, and Human Health. The Agriculture segment develops seed traits, agrochemical products, and agro biological products to improve plant performance. The Industrial Applications focuses on the development and commercialization of improved castor bean seeds for industrial uses. The Human Health segment involves discovery and development of human microbiome-based therapeutics. The company was founded by Amir Barzilay and Hagai Karchi on October 10, 1999 and is headquartered in Rehovot, Israel.

Metrics

Overview

  • HQRehovot, HM
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerEVGN
  • Price$2.511159-0.98%

Trading Information

  • Market Cap$13.68M
  • Float98.34%
  • Average Daily Volume (1m)12,851
  • Average Daily Volume (3m)19,632
  • EPS-$14.80

Company

  • Revenue$35.07M
  • Rev Growth (1yr)42.61%
  • Net Income-$20.19M
  • Gross Margin-25.82%
  • EBITDA Margin-600.00%
  • EBITDA-$20.43M
  • EVN/A
  • EV/RevenueN/A
  • P/EN/A
  • P/S1.37
  • P/B4.15